The STRiDE (Spondylolisthesis Treated with an iO-Flex System enabled Decompression) study is designed to test the effectiveness of the system in treating patients with spinal stenosis and stable grade I degenerative spondylolisthesis. The trial will compare the system to the current standard of care.
The trial will enroll up to 150 patients at 30 medical centers, with an approximate endpoint of two years. Jed Vanichkachorn, MD, an orthopedic surgeon at Tuckahoe Orthopaedics in Richmond, Va., recently performed the first clinical study case.
Related Articles on Spine Devices:
Patent Infringement Trial Underway for Medtronic and NuVasive
Spine Wave Receives FDA Clearance for Lateral Approach Spine Device
VG Innovations Launches Spinal System for Low Back Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.